ProPhase Labs, Inc. (PRPH)
OTCMKTS · Delayed Price · Currency is USD
0.0500
-0.0100 (-16.67%)
At close: Jul 30, 2026
ProPhase Labs Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.03 | 0.09 | 0.68 | 1.61 | 9.11 | 8.41 |
Short-Term Investments | - | - | - | 3.13 | 8.33 | 9.11 |
Cash & Short-Term Investments | 0.03 | 0.09 | 0.68 | 4.74 | 17.44 | 17.51 |
Cash Growth | -64.77% | -86.73% | -85.68% | -72.84% | -0.43% | 107.13% |
Accounts Receivable | 1.54 | 1.54 | 20.06 | 35.81 | 37.05 | 37.71 |
Inventory | 0.07 | 0.07 | 1.14 | 2.29 | 3.98 | 4.6 |
Other Current Assets | 1.47 | 1.45 | 8.76 | 4.74 | 2.37 | 1.5 |
Total Current Assets | 3.11 | 3.15 | 30.64 | 47.59 | 60.83 | 61.32 |
Net Property, Plant & Equipment | 1.71 | 2.03 | 11.62 | 14.9 | 11.35 | 10.35 |
Other Intangible Assets | 6.52 | 7.17 | 9.75 | 12.33 | 8.48 | 10.85 |
Goodwill | 3.97 | 3.97 | 5.23 | 5.23 | 5.71 | 5.71 |
Long-Term Investments | 43.27 | 43.49 | - | - | - | - |
Other Long-Term Assets | 0.15 | 0.06 | 5.97 | 11.88 | 1.28 | 1.07 |
Total Assets | 58.73 | 59.87 | 63.2 | 91.93 | 87.65 | 89.3 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 41.74 | 40.56 | 13.72 | 8.64 | 5.91 | 7.03 |
Accrued Expenses | 0.05 | 0.05 | 0.18 | 0.34 | 1.11 | 1.99 |
Short-Term Debt | 5.41 | 5.16 | 3.21 | - | - | - |
Current Portion of Leases | 3.05 | 2.82 | 3.36 | 2.79 | 0.3 | 0.66 |
Unearned Revenue | 1.84 | 1.5 | 1.7 | 2.38 | 2.5 | 2.03 |
Other Current Liabilities | 4.01 | 2.99 | 9.97 | 6.7 | 6.26 | 3.81 |
Total Current Liabilities | 56.11 | 53.08 | 32.13 | 20.86 | 16.08 | 15.52 |
Long-Term Debt | - | - | 11.65 | 7.33 | 2.4 | 10.04 |
Long-Term Leases | 0.45 | 0.64 | 6.35 | 8.33 | 4.26 | 4.2 |
Other Long-Term Liabilities | 2.79 | 2.64 | 5.71 | 6.02 | 1.28 | 0.91 |
Total Long-Term Liabilities | 3.24 | 3.28 | 23.71 | 21.69 | 7.94 | 15.14 |
Total Liabilities | 59.34 | 56.36 | 55.85 | 42.54 | 24.02 | 30.67 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0 | 0 | 0.02 | 0.02 | 0.02 |
Treasury Stock | -49.64 | -49.64 | -64 | -64 | -58.03 | -48.41 |
Additional Paid-in Capital | 127.71 | 126.48 | 129.94 | 118.69 | 109.14 | 104.55 |
Accumulated Other Comprehensive Income | -0.2 | -0.2 | -0.2 | -0.3 | 0.76 | -0.18 |
Retained Earnings | -78.49 | -73.14 | -58.39 | -5.03 | 11.75 | 2.64 |
Shareholders' Equity | -0.61 | 3.51 | 7.35 | 49.38 | 63.63 | 58.63 |
Total Liabilities & Equity | 58.73 | 59.87 | 63.2 | 91.93 | 87.65 | 89.3 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 8.91 | 8.62 | 24.57 | 18.46 | 6.96 | 14.9 |
Net Cash (Debt) | -8.88 | -8.53 | -23.9 | -13.72 | 10.48 | 2.61 |
Net Cash Growth | - | - | - | - | 301.11% | - |
Net Cash Per Share | -0.83 | -1.00 | -11.95 | -7.97 | 5.62 | 1.42 |
Book Value | -0.61 | 3.51 | 7.35 | 49.38 | 63.63 | 58.63 |
Book Value Per Share | -0.06 | 0.41 | 3.68 | 28.70 | 34.12 | 31.88 |
Tangible Book Value | -11.1 | -7.63 | -7.63 | 31.82 | 49.45 | 42.07 |
Tangible Book Value Per Share | -1.04 | -0.90 | -3.81 | 18.49 | 26.51 | 22.87 |